Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed)
Last verified by NonDilute: 2026-04-29. Official notice and agency instructions control.
Free or heavily subsidized access to world-class genomic platforms and expert statistical support for gene discovery—no clinical trials.
Report stale or inaccurate summary
What this is
This is an NIH-wide initiative managed by NHGRI that offers access to cutting-edge genomic platforms and expert statistical genetics consultation—services most individual labs cannot efficiently perform in-house. Eligible applicants can access CIDR's sequencing, genotyping, and data analysis capabilities to support gene discovery and biobank enrichment projects. The program is open to a wide range of institution types including universities, nonprofits, small businesses, and government entities. Note: Clinical trials are not eligible.
Who can apply
Extremely broad: includes academic institutions, nonprofits (with or without 501(c)(3) status), small businesses, for-profit companies, tribal governments, and local/state government entities. Clinical trial research is explicitly not allowed.
Eligible applicant types
- Public and State controlled institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Private institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- State governments
- Independent school districts
- Small businesses
- City or township governments
- Public housing authorities/Indian housing authorities
- For profit organizations other than small businesses
- County governments
- Native American tribal organizations (other than Federally recognized tribal governments)
- Native American tribal governments (Federally recognized)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Special district governments
Full description — from the agency
The Center for Inherited Disease Research (CIDR) high-throughput genotyping, sequencing and supporting statistical genetics services are designed to aid the identification of genes or genetic modifications that contribute to human health and disease or to enhance existing collections of well-phenotyped specimens in biorepositories by the addition of genotype or next-generation sequence data. The laboratory specializes in genomic services that cannot be efficiently carried out in individual investigator laboratories. CIDR provides the most up-to-date platforms, services and statistical genetic support. This is an NIH-wide initiative that is managed by NHGRI. Information about current services offered can be accessed via: http://www.cidr.jhmi.edu.
Topics: genomic sequencing · genotyping services · inherited disease research · biorepository · statistical genetics
Public-source funding discovery only. This summary is generated from public agency data and may be incomplete or stale. NonDilute is not affiliated with, endorsed by, or acting on behalf of any government agency. Official notices and agency instructions control. NonDilute does not determine eligibility, provide grant-writing advice, or guarantee funding.